Study finds that disease-modifying therapies for Alzheimer’s, lecanemab and donanemab, can extend independence in daily activities by up to 13...

The US Food and Drug Administration (FDA) has approved semaglutide (Ozempic, Novo Nordisk) for reducing the risk for worsening kidney disease and...

Competitive: Worldwide Clinical Trials: Who we are We're a global, midsize CRO that pushes boundaries, innovates and invents because the path to a...

A new drug called sotagliflozin, recently approved by the U.S. Food and Drug Administration (FDA), may help people with type 2 diabetes and kidney...

A national study seeking more effective treatment for deadly metaplastic breast cancer has identified two inhibitor drugs with the potential to...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular...

AIM Vaccine Co., Ltd., a leading PRC vaccine company, announced today that its independently developed mRNA RSV (respiratory syncytial virus) vaccine...

February 11, 2025 -- A clinical trial supported by the National Institutes of Health (NIH) is testing an experimental treatment designed to help...

Researchers at Texas A&M University College of Medicine have developed a new therapy that may slow the progression of Alzheimer’s disease by several...

Heart disease, also called cardiovascular disease, can have serious consequences. It's the leading cause of death for adults in the U.S. Medical...